Insider Transactions

What Contineum Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	9	30
Total trades	18	49

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

Common stock only — 49 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Stengone Carmine N.	CEO and President	Aug 03	Open-market sale · S	−2,500	$16.01	−$40K	17,217
Stengone Carmine N.	CEO and President	Aug 03	Exercise / conversion · M	+2,500	$1.01	+$2.53K	19,717
Lorrain Daniel S.	Chief Scientific Officer	Jul 09	Open-market sale · S	−25	$16.00	−$400	135,202
Lorrain Daniel S.	Chief Scientific Officer	Jul 09	Exercise / conversion · M	+25	$1.01	+$25.3	135,227
Stengone Carmine N.	CEO and President	Jul 08	Open-market sale · S	−2,500	$16.00	−$40K	17,217
Stengone Carmine N.	CEO and President	Jul 08	Exercise / conversion · M	+2,500	$1.01	+$2.53K	19,717
Lorrain Daniel S.	Chief Scientific Officer	Jul 08	Open-market sale · S	−1,015	$16.00	−$16.2K	135,202
Lorrain Daniel S.	Chief Scientific Officer	Jul 08	Exercise / conversion · M	+1,015	$1.01	+$1.03K	136,217
Lorrain Daniel S.	Chief Scientific Officer	Jul 01	Open-market sale · S	−2,501	$16.24	−$40.6K	135,202
Lorrain Daniel S.	Chief Scientific Officer	Jul 01	Open-market sale · S	−5,852	$15.67	−$91.7K	137,703
Lorrain Daniel S.	Chief Scientific Officer	Jul 01	Exercise / conversion · M	+4,183	$1.01	+$4.22K	143,555
Stengone Carmine N.	CEO and President	Jun 30	Open-market sale · S	−10,000	$16.01	−$160K	17,217
Stengone Carmine N.	CEO and President	Jun 30	Exercise / conversion · M	+2,500	$1.26	+$3.15K	27,217
Stengone Carmine N.	CEO and President	Jun 30	Exercise / conversion · M	+7,500	$1.01	+$7.58K	24,717
Watkins Tim	CMO & Head of Development	Jun 30	Open-market sale · S	−10,833	$16.02	−$174K	8,961
Watkins Tim	CMO & Head of Development	Jun 30	Exercise / conversion · M	+10,833	$4.50	+$48.7K	19,794
Lorrain Daniel S.	Chief Scientific Officer	Jun 30	Open-market sale · S	−28,826	$16.04	−$462K	139,372
Lorrain Daniel S.	Chief Scientific Officer	Jun 30	Exercise / conversion · M	+28,826	$1.01	+$29.1K	168,198
Lorrain Daniel S.	Chief Scientific Officer	Jun 01	Open-market sale · S	−4,170	$13.16	−$54.9K	139,372
Lorrain Daniel S.	Chief Scientific Officer	May 01	Open-market sale · S	−300	$13.84	−$4.15K	143,542

Page 1 of 3 · showing the 20 most recent Sign up free to view all 56 transactions and filter by insider →